Indivior

Richmond, United States

Indivior is a specialty pharmaceuticals business.

$450.0M raised

Mar 2026

Post-IPO Debt

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Indivior raised?

Indivior has raised $450.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.

Who are Indivior's investors?

Indivior's investors include Oaktree Capital Management, Piper Sandler.

Where is Indivior headquartered?

Indivior is headquartered in Richmond, United States.

What does Indivior do?

Indivior is a specialty pharmaceuticals business.

What stage is Indivior at?

Indivior is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 12, 2026.

MLA

"Indivior — Funding & Investors." VCBacked, March 12, 2026, https://www.vcbacked.co/company/indivior. Accessed July 2, 2026.

APA

VCBacked. (2026). Indivior — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/indivior

Wikipedia (cite web)

{{cite web |title=Indivior — Funding & Investors |url=https://www.vcbacked.co/company/indivior |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 12, 2026.